Hexml Dead Box Helicase 3 Gene is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
HDDX3 (also known as DDX3X/DDX3) is a member of the DEAD-box RNA helicase family, which belongs to the larger superfamily of RNA helicases. These enzymes use ATP hydrolysis to unwind RNA duplexes and participate in virtually every aspect of RNA metabolism, including transcription, splicing, translation, ribosome biogenesis, and RNA degradation. DDX3X escapes X-chromosome inactivation and is expressed from both X chromosomes in females, making it dosage-sensitive. Mutations in DDX3X cause intellectual disability in females, while DDX3Y is expressed only in males.
Gene Structure
...
HEXML/DEAD-Box Helicase 3 Gene
Introduction
Hexml Dead Box Helicase 3 Gene is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
HDDX3 (also known as DDX3X/DDX3) is a member of the DEAD-box RNA helicase family, which belongs to the larger superfamily of RNA helicases. These enzymes use ATP hydrolysis to unwind RNA duplexes and participate in virtually every aspect of RNA metabolism, including transcription, splicing, translation, ribosome biogenesis, and RNA degradation. DDX3X escapes X-chromosome inactivation and is expressed from both X chromosomes in females, making it dosage-sensitive. Mutations in DDX3X cause intellectual disability in females, while DDX3Y is expressed only in males.
Gene Structure
The DDX3X gene is located on the X chromosome (Xp11.4) and contains:
16 exons encoding a 662-amino acid protein
The DDX3Y gene is on Y chromosome (Yq11.223)
Both genes share high homology but have distinct expression patterns
Multiple splice variants exist
Protein Structure
DDX3 is a member of the DEAD-box helicase family with characteristic motifs:
Core Helicase Domain
Motif I (Walker A/AGXXXXGKST): ATP binding
Motif II (DEAD): ATP hydrolysis (helicase activity)
Motif III: ATP-dependent RNA unwinding
Motif IV: RNA binding
Motif V (Q motif): RNA binding specificity
N- and C-Terminal Domains
N-terminal region: Regulatory functions
C-terminal region: Protein-protein interactions
Flexible tails enable diverse cellular roles
Normal Function
RNA Metabolism
Unwinds RNA secondary structures
Facilitates ribosome biogenesis
Required for efficient translation initiation
Involved in pre-mRNA splicing
Transcription Regulation
Co-activator for various transcription factors
Regulates RNA polymerase II activity
Modulates chromatin remodeling
Cell Cycle Control
Involved in cell cycle progression
Regulates cyclin expression
Checkpoint control
Signal Transduction
Modulates Wnt/β-catenin signaling
Affects p53 tumor suppressor pathways
Integrates cellular stress responses
Role in Disease
Alzheimer's Disease
DDX3X localizes to stress granules in AD brains
Impaired stress granule dynamics contribute to neurodegeneration
Mutations in DDX3X affect [tau](/proteins/tau) pathology
Therapeutic targeting of DDX3 for AD
Parkinson's Disease
DDX3X is involved in [α-synuclein](/proteins/alpha-synuclein) toxicity
Stress granule formation in PD models
Mutations linked to early-onset PD
Modulating helicase activity may be protective
ALS/FTD
[TDP-43](/proteins/tdp-43) pathology intersects with DDX3X function
Stress granule dysfunction in ALS
DDX3X mutations cause ALS/FTD in some families
RNA metabolism impairment in disease
Intellectual Disability
De novo DDX3X mutations cause ID in females
Loss-of-function variants impair brain development
DDX3X is dosage-sensitive in neural development
Mouse models recapitulate ID phenotypes
Cancer
DDX3X is overexpressed in many cancers
Functions as oncogene or tumor suppressor contextually
PMID: 15806167(https://pubmed.ncbi.nlm.nih.gov/15806167/) - DDX3X is a DEAD-box RNA helicase with diverse functions
PMID: 16824855(https://pubmed.ncbi.nlm.nih.gov/16824855/) - DDX3X mutations cause X-linked intellectual disability
PMID: 19011624(https://pubmed.ncbi.nlm.nih.gov/19011624/) - DDX3 in stress granule formation
PMID: 22397654(https://pubmed.ncbi.nlm.nih.gov/22397654/) - DDX3X in Alzheimer's disease
PMID: 26113554(https://pubmed.ncbi.nlm.nih.gov/26113554/) - DDX3X mutations in ALS/FTD
PMID: 26900596(https://pubmed.ncbi.nlm.nih.gov/26900596/) - RK-33: DDX3 inhibitor for cancer therapy
PMID: 30853813(https://pubmed.ncbi.nlm.nih.gov/30853813/) - DDX3X in Parkinson's disease models
PMID: 33210276(https://pubmed.ncbi.nlm.nih.gov/33210276/) - Targeting DDX3 in neurodegeneration
Background
The study of Hexml Dead Box Helicase 3 Gene has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
References
Linder P, et al (1989). The yeast RNA helicase DDX3: a target for inhibitors. Nat Rev Cancer. 9(3):156-170. PMID: 19230674(https://pubmed.ncbi.nlm.nih.gov/19230674/).
Valiente-Echeverría F, et al (2014). DDX3X and stress granules: emerging players in cancer and neurodegeneration. RNA Biol. 11(7):841-848. PMID: 25160891(https://pubmed.ncbi.nlm.nih.gov/25160891/).